Recent Articles from GlobeNewswire

KFC replaces brand icon Colonel Sanders with Kyle ‘F’ Connor on its famous buckets just in time for the Jets Round 2 playoffs run

With IT leadership gaps growing, companies are turning to nearshore staffing to align teams and drive project success

BROOKLYN, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Olympian Motors announced a strategic partnership with Foxconn, a global leader in advanced manufacturing and electronics, to develop and launch Olympus OS —an open, modular, AI-defined vehicle operating system. Olympus OS is engineered to disrupt the legacy model of automotive software, middleware, and machine learning infrastructure.

WASHINGTON, May 09, 2025 (GLOBE NEWSWIRE) -- The Trustees of The 2023 ETF Series Trust and The 2023 ETF Series Trust II ("The Trusts") announced today that, following an extensive due diligence process, Tidal Financial Group has been selected as the preferred service provider to support and grow the Trusts, replacing the Goldman Sachs ETF Accelerator platform as it winds down operations.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Grindr, Inc. (NYSE:GRND) on behalf of long-term stockholders following a class action complaint that was filed against Grindr on May 1, 2025. Our investigation concerns whether the board of directors of Grindr have breached their fiduciary duties to the company.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or the "Company") (NASDAQ: BITF) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-02630, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Bitfarms securities between March 21, 2023 and December 9, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

MEXICO CITY, May 09, 2025 (GLOBE NEWSWIRE) -- Grupo Aeromexico S.A.B. de C.V. (“Aeromexico”) reports its April 2025 operational results:

Honorees from Sports, Entertainment, Healthcare and More Inducted During May 8 Ceremony, Hosted by Courtney B. Vance in San Diego

JACKSONVILLE, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) today announced it has reached a tentative agreement with the Brotherhood of Locomotive Engineers and Trainmen (BLET) on a new five-year single-system agreement covering approximately 3,400 locomotive engineers.

New York, NY, May 09, 2025 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company has timely deposited into the Company’s trust account (the “Trust Account”), an aggregate of $40,312, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from May 12, 2025 to June 12, 2025 (the “Extension”). The Extension is the tenth of up to twelve (12) one-month extensions permitted under the August 8, 2024 amendment to the Company’s Amended and Restated Certificate of Incorporation that allows the Company’s board of directors, in its sole discretion and without another stockholder vote, to elect to extend the termination date by one additional month each time up until August 12, 2025, or the closing of the Company’s initial business combination.

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current Standards of Care in Matched Patient Populations

Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label extension

~ Ended First Quarter with $759.0 Million in Cash/Investments ~

SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Open Lending Corporation (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025. Open Lending is a provider of loan services to automotive lenders.

SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Canopy Growth Corporation (NASDAQ: CGC) securities between May 30, 2024 and February 6, 2025. Canopy, together with its subsidiaries, produces, distributes, and sells cannabis and hemp-based products for recreational and medical purposes.

                

CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:

SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Viatris Inc. (NASDAQ: VTRS) securities between August 8, 2024 and February 26, 2025. Viatris is a global healthcare company that supplies medicines to patients across more than 165 countries and territories via its 26 manufacturing and packaging sites worldwide.

Loch to lead firm’s consulting practice across Arabella Advisors and Redstone Strategy Group

MILWAUKEE, May 09, 2025 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of April 30, 2025 totaled $164.4 billion. Artisan Funds and Artisan Global Funds accounted for $80.2 billion of total firm AUM, while separate accounts and other AUM1 accounted for $84.2 billion.

SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Solaris Energy Infrastructure, Inc. (NYSE: SEI) securities between July 9, 2024 and March 17, 2025. Solaris provides equipment used in the completion of oil and natural gas wells in the United States. On July 9, 2024, Solaris announced that it has entered into an agreement to acquire Mobile Energy Rentals LLC (“MER”).

Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25

        - Stenoparib continues to demonstrate clinical benefit in heavily pre-treated ovarian cancer, with two patients remaining on treatment for more than 19 months- Initiated utilization of share repurchase program- Cash and restricted cash balance of approximately $27 million at end of Q1 2025, reinforcing financial stability

ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT.

SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 183,885 shares of the Company’s common stock to seven new employees (the “Inducement Grants”) on May 6, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).

MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 6,600 shares of its common stock to twelve newly-hired employees, with a grant date of May 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public offering price of $5.25 per share on May 8, 2025, pursuant to the full exercise of the option granted by Exagen to the underwriter in connection with its previously announced public offering of 3,350,000 shares of common stock, which closed on May 9, 2025.

BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 111,750 shares of Class A common stock and restricted stock units (RSUs) for 62,575 shares of Class A common stock to eleven (11) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

St. Louis, MO, May 09, 2025 (GLOBE NEWSWIRE) -- Meeting Professionals International (MPI), the world’s largest global meeting and event industry association, has opened registration for its World Education Congress (WEC) 2025, taking place June 18–20 at the newly expanded America’s Center Convention Complex in St. Louis. This premier event offers unparalleled education, networking, and business opportunities tailored for meeting and event professionals.​  

WOBURN, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees.

OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter ended March 31, 2025.

WINTER PARK, Fla. and SALT LAKE CITY

NEW YORK, NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) --  Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the “Trust Account”) an aggregate of $874.78 to fund the one-month extension from May 11, 2025 to June 11, 2025. This deposit was funded via a convertible promissory note with a principal amount of up to $180,000 issued by the Company to Scilex Holding Company (Nasdaq: SCLX, “Scilex”), which bears no interest and is repayable on the earlier of the effective date of the consummation of the Company’s initial business combination or the date of the liquidation of the Company. Upon the closing of a business combination, the note is convertible, at Scilex’s discretion, into the Company’s Class A ordinary shares at a conversion price of $10.00 per share. Any future drawdowns of the remaining $57,795.52 principal amount available under the convertible promissory note are expected to fund future one-month extensions as necessary to provide additional time for the Company to complete a business combination.

Washington, D.C., May 09, 2025 (GLOBE NEWSWIRE) -- The Thurgood Marshall College Fund (TMCF) added Hampton University (Hampton) in Virginia and Hinds Community College at Utica (Hinds CC) in Mississippi to its member schools, now totaling 57 institutions consisting of historically Black colleges and universities (HBCUs), predominantly Black institutions (PBIs) and historically Black community colleges (HBCCs).

Southern Nevada’s economy is set to benefit from a major boost as a trio of forward-thinking companies—representing the automotive, health innovation, and artificial intelligence sectors—prepare to launch or expand operations in the region.

Las Vegas, Nevada, May 09, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Tuesday, May 13, 2025 at 1:00 p.m. ET to discuss its first quarter 2025 operating results.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Hans Vestberg, Chairman and CEO of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 14 at 8:00 a.m. ET. His remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or the “Company”) (NYSE: CLF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass Diversified (“CODI” or the “Company”) (NYSE: CODI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Expansion to boost cargo capacity, attract $3.9 billion in foreign investment, and position Dominican Republic as a regional nearshoring and trade hub

Emmy-Award Winning Television Host and Lifestyle Expert, Marisa Brahney, Shares Her List of Must-Haves for Mother’s Day

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) is now trading under the single-letter ticker symbol ‘B’ on the New York Stock Exchange, reinforcing the Company’s position as a global gold and copper mining leader.

Kings Bay, GA, May 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE | B-ROLL AND INTERVIEW LINK INCLUDED:

BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Available in Four States — Having already established a strong presence in Massachusetts and New Hampshire, FamilyWell Health is now extending its reach to Texas and Connecticut, two key states central to the company’s strategic growth plan. The expansion is a direct response to the worsening maternal mental health crisis, resulting in suicide as the number one cause of death during and after pregnancy. 1 in 5 women are diagnosed with postpartum depression, and 80% are unable to access treatment in the U.S. Women, now more than ever, need access to accessible, affordable, and high-quality maternal mental health care.

State legislators, County supervisors highlight critical role of Tejon Master Planned Communities for economic development and growth

Transaction in Own Shares

New 16,000 sq ft factory in Glen Cove, NY, doubles production capacity and reinforces Standard Bots’ position as a leading American robot manufacturer

SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in the following investor conferences in the fiscal fourth quarter of 2025:

CHICAGO, May 09, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) named John J. Whyte, M.D., M.P.H., as its next chief executive officer and executive vice president. Dr. Whyte will assume operational leadership of the nation’s largest physician’s group on July 1, 2025.Dr. Whyte comes to the AMA with a background in clinical medicine, government, and the private sector. A practicing physician for 27 years, he has deep experience in federal, state and local health policy paired with a proven record of strategic management and innovation in the private sector.He served in leadership positions at the Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services, U.S. Food and Drug Administration as well as the media company Discovery Communications. Most recently, he was the chief medical officer at WebMD, the health news and information company based in New York. “Dr. Whyte is an exceptionally qualified leader who has distinguished himself across many fronts. He is uniquely positioned to lead the AMA at this pivotal time and offers a deep and nuanced understanding of the AMA’s mission, governance, and evolving role—ensuring both continuity and meaningful progress toward the association’s goals,” said AMA Board Chair, Michael Suk, M.D., J.D., M.P.H., M.B.A.On his appointment, Dr. Whyte said, “I am honored to join the AMA as CEO and serve all patients and physicians across the country. I have tremendous respect and admiration for this venerable, science-based organization and its important work that improves the lives of millions of people. I see significant opportunities for a strong and vibrant AMA to fulfill its core mission to promote the art and science of medicine and the betterment of public health.”A board-certified internist, Dr. Whyte completed his medical degree at Hahnemann University School of Medicine, conducted his residency training at Duke University Medical Center, and earned his Master of Public Health degree in health policy and management at Harvard University.Dr. Whyte has written extensively for both professional and consumer audiences, including five best-selling books. A recognized leader during the COVID-19 pandemic, he was named one of the Top 20 Health Influencers for his public health leadership.Dr. Whyte will succeed James L. Madara, M.D., who announced last June plans to end his 14-year tenure as AMA CEO at the conclusion of his current contract.

BALA CYNWYD, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

All amounts are in U.S. dollars unless otherwise stated

Hogan, President of CMB Regional Centers, has officially been elected for a third term

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

The base shelf prospectus is accessible, and the shelf prospectus supplement and any amendment to the documents will be accessible within two business days through SEDAR+

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or the “Company”) (NASDAQ: TTWO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  XP Inc. (“XP” or the “Company”) (NASDAQ: XP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Hyra Network strengthens global presence across two leading tech stages, engaging 40+ top VCs and 700+ enterprises

NEWPORT NEWS, Va., May 09, 2025 (GLOBE NEWSWIRE) -- More than two dozen high school seniors know what they’ll be doing after graduation this year, after accepting offers to begin their shipbuilding careers at HII’s (NYSE: HII) Newport News Shipbuilding division.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

ISTANBUL, May 09, 2025 (GLOBE NEWSWIRE) -- Blackshape S.p.A., part of the high-tech Italian industrial Holding Angel (active in the railway, aerospace, and digital mechatronics sectors), is among the leading players at the International Flight Training Exhibition (IFTE), taking place in Istanbul from May 9 to 11, 2025.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Pony AI Inc. (“Pony” or the “Company”) (NASDAQ: PONY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.